MyNeo Revenue and Competitors

Ghent,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MyNeo's estimated annual revenue is currently $3.1M per year.(i)
  • MyNeo's estimated revenue per employee is $155,000

Employee Data

  • MyNeo has 20 Employees.(i)
  • MyNeo grew their employee count by 33% last year.

MyNeo's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
Principal Data ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.7M6120%N/AN/A
Add Company

What Is MyNeo?

myNEO leads in Personalized Medicine and genomic-informed drug discovery in the key therapeutic areas of oncology and immunology. The myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that predicts the most efficacious targets for each individual cancer patient, key to developing a successful personalized immunotherapy. In parallel, the DataScovery© platform continuously screens public and privately gathered databases to discover new immunogenic targets for both untackled cancer indications and new infectious diseases. To coninously increase clinical performance of the platform, data of all patients across biopharma partners are combined into one centralized myNEO network.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$3.1M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3M210%N/A
#2
$2.2M225%N/A
#3
$2.2M225%N/A
#4
$3.7M244%N/A
#5
$2.4M2865%N/A